+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07695363

Comparing Restrictive and Liberal Fluid Management Strategies During Liver Transplant Surgery to Improve Recovery and Reduce Complications

Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2026-07-10

866

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two fluid management strategies during liver transplantation for adults with end-stage liver disease ESLD. It evaluates whether a low splanchnic blood volume restrictive fluid management approach, combined with phlebotomy and use of blood pressure medications during surgery, improves patient recovery and reduces severe postoperative complications compared to a more liberal fluid administration strategy. The study includes patients undergoing liver transplantation and follows them for up to 12 months after surgery. Participants are randomly assigned to one of two groups the restrictive group receives phlebotomy at the start of surgery with limited fluids and medications to maintain blood pressure, while the liberal group follows a goal-directed therapy that administers fluids to optimize heart output. Blood collected during phlebotomy is transfused back during reperfusion in the restrictive group. Both groups receive fluids to replace blood loss or treat severe instability. The study includes an initial pilot phase and then a larger phase to assess these approaches. During the study, participants are monitored from surgery through their hospital stay and up to one year post-transplant. Researchers will assess severe complications within 30 days after surgery, blood transfusions, blood loss, quality of recovery at 7 days, kidney function, graft health, infection, ICU stays, hospital length, readmissions, survival, quality of life, and costs. Follow-up includes clinical evaluations and quality of life measures to understand the impact of the fluid management strategy on recovery and long-term outcomes.

CONDITIONS

Brief Title

Restrictive Fluid Management In Liver Transplantation (REFIL)

Research Team

M

Manuela Mbacfou, MSc

F

François Martin Carrier, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here